The effect of selenium in patients with Covid-19

Evaluation of the effectiveness of selenium added to intravenous nutrition therapy on mortality and duration of ICU hospitalization in patients with COVID-19 disease

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160919029870N3

Enrollment

Registered

2020-11-24

Start date

2020-03-20

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. COVID-19, virus identified

Interventions

Intervention 1: Intervention group: according to the protocol, in this group, one mg of selenium in the form of stat (initial dose and amount) and 500 micrograms of intravenous infusion for 15 minutes

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with Covid-19 disease by infectious disease physician Patients who are hospitalized in the special ward and three days have been passed since their hospitalization Patients who are intubated and connected to a ventilator

Exclusion criteria

Exclusion criteria: Patients with covid-19 who are not intubated.

Design outcomes

Primary

Measure	Time frame
Duration of hospitalization. Timepoint: The first day of patients' arrival and the day of discharge from the ICU or death of patients. Method of measurement: Number of days patients are admitted to the ICU.	—

Secondary

Measure	Time frame
Death. Timepoint: Daily from the day of admission to the special ward until discharge or death of patients. Method of measurement: Document.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamed Shafiee

Ghoum University of Medical Sciences

rheidarifar@muq.ac.ir+98 25 3133 1602

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026